Niagen Bioscience (NAGE) Retained Earnings: 2011-2025
Historic Retained Earnings for Niagen Bioscience (NAGE) over the last 12 years, with Sep 2025 value amounting to -$168.7 million.
- Niagen Bioscience's Retained Earnings rose 10.80% to -$168.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$168.7 million, marking a year-over-year increase of 10.80%. This contributed to the annual value of -$181.9 million for FY2024, which is 4.49% up from last year.
- Per Niagen Bioscience's latest filing, its Retained Earnings stood at -$168.7 million for Q3 2025, which was up 2.64% from -$173.2 million recorded in Q2 2025.
- Niagen Bioscience's 5-year Retained Earnings high stood at -$154.8 million for Q2 2021, and its period low was -$191.0 million during Q2 2024.
- Its 3-year average for Retained Earnings is -$184.5 million, with a median of -$189.1 million in 2024.
- In the last 5 years, Niagen Bioscience's Retained Earnings fell by 19.13% in 2021 and then rose by 10.80% in 2025.
- Niagen Bioscience's Retained Earnings (Quarterly) stood at -$169.0 million in 2021, then decreased by 9.79% to -$185.5 million in 2022, then declined by 2.68% to -$190.5 million in 2023, then increased by 4.49% to -$181.9 million in 2024, then increased by 10.80% to -$168.7 million in 2025.
- Its Retained Earnings was -$168.7 million in Q3 2025, compared to -$173.2 million in Q2 2025 and -$176.8 million in Q1 2025.